Skip to content

Abstract 14268: Comparative Analysis of Postoperative Outcomes Following Surgical vs. Transcatheter Edge-to-Edge Mitral Valve Repair for Secondary Mitral Regurgitation

Nov 2026 · Circulation · 0 citations

Abstract

Background: Secondary mitral regurgitation (SMR) remains a significant clinical challenge in patients with left ventricular dysfunction.Surgical mitral valve repair (SMVr) has historically been the standard intervention; however, transcatheter edge-to-edge repair (TEER) has emerged as a less invasive therapeutic alternative for high-risk patients. This meta-analysis evaluates the comparative safety and efficacy of SMVr versus TEER in patients with symptomatic SMR. Methods: Systematic database search identified 3,149 studies reporting on TEER or SMVr for treatment of SMR from inception till May 2024. A total of 10 studies were included after screening according to PRISMA guidelines.Analysis was done using a randome effects model.The outcomes of interest were all-cause mortality,length of hospital stay,cardiovascular outcomes,NYHA functional class improvement, post operative LVEF changes etc. Results: A total of 10 postoperative outcomes and complications were analyzed. Compared to TEER, SMVr was associated with a significantly higher risk of all-cause mortality (RR 1.62, 95% CI 1.17-2.25,p=0.0035) and a longer length of hospital stay (SMD 0.91, 95% CI 0.22-1.60,p=0.0093).SMVr was also associated with increased rates of cardiac arrest (RR 1.52, 95% CI 1.02-2.28,p=0.0417), prolonged mechanical ventilation (RR 1.80, 95% CI 1.12-2.88, p=0.0143), and post-procedural cerebral infarction (RR 2.41;,95% CI 1.30-4.48, p=0.0054).No significant differences were observed between the two groups regarding in-hospital mortality (p=0.5275), cardiac tamponade (p=0.1635), post-procedural thrombosis (p=0.7776), NYHA functional class III/IV at 24 months (p=0.7668) or, post-procedural left ventricular ejection fraction (p=0.5738). Conclusion: In patients with secondary mitral regurgitation, TEER is associated with significantly lower all-cause mortality, shorter hospital stays, and reduced procedural morbidity compared to SMVr.While efficacy endpoints were comparable, TEER's superior safety makes it the preferred intervention for patients at high surgical risk.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.